Indian celebrity-backed fashion brands struggle due to lack of clear brand identity, inconsistent quality, and market ...

Metsera, Inc. (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, ...

Bollywood actresses who are making waves with their own fashion labels while balancing their acting career with an ace; from ...

Ranbir Kapoor’s entrepreneurial venture, ARKS, officially launches today with a debut collection of elevated essentials that ...

From timeless legends like Madhuri Dixit and Aishwarya Rai to rising stars like Triptii Dimri and Janhvi Kapoor, here’s a ...

NEW YORK, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: MTSR) (“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog ...

Permits have been filed for the construction of a 4-story residential building at 1848 Guerlain St. in the Parkchester neighborhood of the Bronx.

Metsera, Inc MTSR IPO will take place January, 31 on the NASDAQ exchange under the ticker MTSR. The company is offering shares at an expected price between $15.00 and $17.00 per share with an insider ...

I’m neutral (hold) on MTSR’s IPO. New York, NY-based Metsera, Inc. was founded to develop a range of oral and injectable NuSH peptides to reduce obesity and overweight conditions. Management ...

The company is developing injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. Its most advanced candidate, MET-097i is a ...

(“Metsera”), a clinical-stage biotechnology company developing next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides to treat obesity, overweight and related ...